Atorvastatin sodium

CAS: 134523-01-6 F: C33H34FN2NaO5 W: 580.62

Atorvastatin sodium is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipid

Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	Atorvastatin sodium is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids. Atorvastatin sodium inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively[1][2][3][4][5].
Invitro	Atorvastatin sodium 通过下调心肌梗死后心肌细胞中 GRP78、caspase-12 和 CHOP 的表达来减少心肌细胞凋亡，并响应心力衰竭和血管紧张素 II (Ang II) 刺激而激活内质网 (ER) 应激[4]。
In Vivo	Atorvastatin（20-30 mg/kg；口服灌胃；每天一次；持续 28 天；ApoE−/− 小鼠）sodium 显着降低内质网 (ER) 应激信号蛋白、凋亡细胞数量，以及 Ang II 诱导的 ApoE-/- 小鼠中 Caspase12 和 Bax 的激活。Atorvastatin sodium 治疗后，IL-6、IL-8、IL-1β 等促炎细胞因子均受到显着抑制[5]。
Name	Atorvastatin sodium
CAS	134523-01-6
Formula	C33H34FN2NaO5
Molar Mass	580.62
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Br J Pharmacol. 2006 Sep;149(1):14-22. [2]. Turner NA, et al. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. J Cardiovasc Pharmacol. 2007 Oct;50(4):458-61. [3]. Nawrocki, J.W., et al., Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol, 1995. 15(5): p. 678-82. [4]. Song XJ, et al. Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response. Int J Med Sci. 2011;8(7):564-72. [5]. Li Y, et al. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm. PLoS One. 2017 Apr 3;12(4):e0174821. [6]. Ming-Bai Hu, et al. Atorvastatin induces autophagy in MDA-MB-231 breast cancer cells. Ultrastruct Pathol. Sep-Oct 2018;42(5):409-415.